Stephanie Fohn

Stephanie Fohn is a seasoned executive and advisor with extensive experience in technology and security sectors. Currently serving on the Board of Directors and as an advisor for DefectDojo and Zentera Systems, Fohn contributes to advancing application vulnerability management and Zero Trust security solutions. As an investor and advisor at PanTher Therapeutics and PeakSpan Capital, Fohn focuses on innovative oncology therapies and growth-stage B2B software companies. Previous leadership roles include President and CEO of NeuVector and Rundeck, where Fohn drove significant advancements in container security and IT automation. Fohn holds a Master's degree from the MIT Sloan School of Management and a Bachelor's degree from the University of Washington.